Helping Life Sciences Organizations Reach More Patients

International Marketing Solutions for the Life Sciences Industry

Get a Free Consult
Dark purple lab drip

Targeted Patient Campaigns for Anywhere in the World, in Any Language

  1. Roughly 80% of clinical trials fail to meet enrollment timelines.
  2. Approximately one-third (30%) of Phase III study terminations are due to enrollment difficulties.
  3. As these statistics make abundantly clear, better patient recruitment processes can drastically improve clinical trial success.

Create Strategic Global Patient Recruitment Campaigns

We can help with our extensive market research, global expertise, and local digital marketing experts

  • Market Insights – Mapping the Patient Journey
  • Cultural Consulting – Adapting Content for Intended Audiences
  • Regulatory Consulting – Advising on Local Regulations (e.g., Promotional Liability in the EU)
  • Medical Writing & Content Development
  • Digital Strategy
  • Translation and Media
  • Technology to Streamline Approval Process
Learn More

Benefits of TransPerfect's Digital Patient Engagement Solutions

Patient recruitment consumes 27% of the cost of development–that is $5.9 billion annually around the world.

  • Icon Timelines

Shrink Timelines for Creating and Launching Campaigns

  • Icon Save Money

Save Money on Campaign Planning and Execution

  • Icon Marketing

Retain More Patients with Improved Targeting and Patient Education

  • Icon Regulatory

Maintain Protocol Adherence and Reduce Compliance Risks

Streamline Patient Recruitment Strategies

A diverse and inclusive patient recruitment strategy is key to ensuring a successful clinical trial. TransPerfect Life Sciences supports pharmaceutical companies in reaching patients, meeting enrollment numbers, and meeting diversity and inclusion goals. With extensive market research and global expertise, our local digital marketing experts develop strategic recruitment marketing plans and messaging that engage patients across all channels.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

20230124-lifesciences-resize-v3_0022_400x160px-hologic_logo.png
untitled_design_4.png
20230124-lifesciences-resize-v3_0016_400x160px-bayer_logo.png
20230124-lifesciences-resize-v3_0015_400x160px-merck_logo.png

Ready to Reach More Patients?

Schedule a free consult.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Thought Leadership

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations.

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects today’s eCOA capabilities or institutional habit. Paper is often framed as the “gold standard,” yet paper-based patient-reported outcome data can be incomplete, error-prone and difficult to ...

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials
Success Stories

Top 10 Pharma Company Overhauls Global COA Program,Cutting Costs by 33% and Errors to Near Zero

Inconsistent standards, stretched timelines, and limited visibility were straining a top 10 pharma company's COA program. Discover how TransPerfect Life Sciences' centralization strategy delivered 99.7% accuracy, 40% less PM oversight, and 33% cost savings across the ...
Blog

Four Years In: What the EU Clinical Trial Regulation Has (and Hasn't) Delivered

When the EU Clinical Trial Regulation (EU CTR No 536/2014) went live for new submissions on January 31, 2022, it promised to transform how clinical trials are authorized and conducted across Europe: a single submission, one decision, and harmonized oversight. Four years in,...
Webinar

How to Make Your Academy Succeed at Global Scale—Lessons Learned on What Works and What Doesn’t

Most life sciences and MedTech companies launch a corporate academy with strong strategic intent, whether that’s executive sponsorship, a named platform, a dedicated budget, or a curriculum mapped to business goals. After launch, however, these same organizations all too often ...
Webinar

IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays

Investigational medicinal product (IMP) labeling sits at the heart of clinical trial supply, impacting departments across pharmaceutical organizations, from clinical operations and regulatory affairs to quality assurance and beyond. When labeling activities are managed across ...
Webinar

The Missing Link: Why Study Design Makes or Breaks a Clinical Trial

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant at OptiTrial, to explore why study design is so often the overlooked "missing link" in clinical ...
Event

C3 Summit 2026 - London

Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to ...